Washington | Business consulting giant McKinsey will pay $US650 million ($1 billion) to end a criminal probe by the Justice Departmentinto the company’s role in bolstering sales of addictive pain pills, prosecutors announced on the weekend.
In what officials described as a landmark case, US attorneys in Massachusetts and Virginia filed charges of conspiracy to misbrand a drug and obstruction.